Showing results (2311-2320 of 2,695) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|February 13, 2019
Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trialsMichael White, Olubukola Idoko, Samba Sow, et al.The Lancet. Infectious Diseases|July 8, 2021
Clinical interventions for tungiasis (sand flea disease): a systematic reviewSolomon Abrha, Jorg Heukelbach, Gregory M Peterson, et al.The Lancet. Infectious Diseases|July 10, 2021
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysisMélanie Drolet, Jean-François Laprise, Dave Martin, et al.The Lancet. Infectious Diseases|July 15, 2021
Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluationTyler M Sharp, Kathryn B Anderson, Leah C Katzelnick, et al.The Lancet. Infectious Diseases|December 28, 2020
Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort studyAisleen Bennett, Louisa Pollock, Naor Bar-Zeev, et al.The Lancet. Infectious Diseases|July 29, 2021
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialShipo Wu, Jianying Huang, Zhe Zhang, et al.The Lancet. Infectious Diseases|July 31, 2021
Biodefence research two decades on: worth the investment?Carrie M Long, Andrea MarziThe Lancet. Infectious Diseases|May 14, 2013
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsJoseph J Eron, David A Cooper, Roy T Steigbigel, et al.The Lancet. Infectious Diseases|May 14, 2013
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trialNina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, et al.The Lancet. Infectious Diseases|March 14, 2013
The search for an HIV cure: tackling latent infectionStephen J Kent, Jeanette C Reece, Janka Petravic, et al.Pageof 270